FDA Adverse Event Injury Summary report: N

GMK-SPHERIKA 02.07.1204L TIBIAL TRAY FIX CEMENTED S.4L

MDR report key: 18111193 · Received November 10, 2023

Report

Report Number
3005180920-2023-00862
Event Type
Injury
Date Received
November 10, 2023
Date of Event
October 12, 2023
Report Date
November 10, 2023
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
JWH
UDI-DI
07630030819902
PMA / PMN Number
K090988
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

BATCH REVIEW PERFORMED ON (B)(6) 2023. LOT 2237762: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 06-DEC-2022. EXPIRATION DATE: 2027-11-22. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED CASE DURING THE PERIOD OF REVIEW. OTHER DEVICES INVOLVED: GMK-SPHERIKA 02.12.0411FL GMK-SPHERE TIBIAL INSERT - FLEX S4L - 11 MM (K140826) LOT 2112458: (B)(4)ITEMS MANUFACTURED AND RELEASED ON 14-OCT-2021. EXPIRATION DATE: 2026-09-29. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH ANOTHER SIMILAR REPORTED CASE DURING THE PERIOD OF REVIEW. GMK-SPHERIKA 02.12.KA05L GMK SPHERIKA FEMORAL COMPONENT S5L CEMENTED (K211004) LOT 2112573: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 3-NOV-2021. EXPIRATION DATE: 2026-10-20. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED CASE DURING THE PERIOD OF REVIEW.

Description of Event or Problem · 0

AT ABOUT 8 MONTHS FROM THE PRIMARY, THE PATIENT CAME IN DUE TO SIGNS OF INFECTION AND THE PATHOGEN IS UNKNOWN. THE SURGEON REVISED ALL MEDACTA HARDWARE AND RE-IMPLANTED PERMANENT COMPONENTS. THE SURGERY WAS COMPLETED SUCCESSFULLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1939333 GMK-SPHERIKA 02.07.1204L TIBIAL TRAY FIX CEMENTED S.4L KNEE TIBIAL TRAY FIX CEMENTED JWH MEDACTA INTERNATIONAL SA 2237762 07630030819902

Patients

Seq Age Sex Outcome Treatment
1 Male Required Intervention